Number of the records: 1  

MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis

  1. 1.
    SYSNO ASEP0480904
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleMicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis
    Author(s) Schneiderová, B. (CZ)
    Naccarati, Alessio (UEM-P)
    Pardini, Barbara (UEM-P)
    Rosa, F. (IT)
    Di Gaetano, C. (IT)
    Jirásková, Kateřina (UEM-P)
    Opattová, Alena (UEM-P)
    Levý, M. (CZ)
    Veskrna, K. (CZ)
    Veškrnová, V. (CZ)
    Buchler, T. (CZ)
    Landi, S. (IT)
    Vodička, Pavel (UEM-P) RID
    Vymetálková, Veronika (UEM-P) RID
    Source TitleMutagenesis. - : Oxford University Press - ISSN 0267-8357
    Roč. 32, č. 5 (2017), s. 533-542
    Number of pages10 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsexcision-repair genes ; bladder-cancer ; tumor-growth
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsNV15-26535A GA MZd - Ministry of Health (MZ)
    LD14050 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    NV15-27580A GA MZd - Ministry of Health (MZ)
    GA17-16857S GA ČR - Czech Science Foundation (CSF)
    Institutional supportUEM-P - RVO:68378041
    UT WOS000413218700007
    EID SCOPUS85032489277
    DOI10.1093/mutage/gex026
    AnnotationHere we provide the first evidence that variations in potential miRNA target binding sites in the 3UTR of PARP1 gene may modulate CRC risk and prognosis after therapy. We investigated eight miRSNPs (rs1804191, rs397768, rs41116 in APC, rs1137918, s227091, rs4585 in ATM, rs712, rs1137282, rs61764370 in KRAS, rs8674 in PARP1 and rs16950113 in SMAD7) for their association with CRC risk in a case–control study (1111 cases and 1469 healthy controls). The role of these miRSNPs was also investigated in relation to clinical outcome on a subset of patients with complete follow-up.
    WorkplaceInstitute of Experimental Medicine
    ContactLenka Koželská, lenka.kozelska@iem.cas.cz, Tel.: 241 062 218, 296 442 218
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.